Shao Jing Tong

Shao Jing Tong

Director of Finance/CFO at REMEGEN CO., LTD.
55 year
Finance
Health Technology
Consumer Services

Profile

Currently, Shaojing Tong holds the position of Chief Financial Officer at InnoCare Pharma Ltd. Mr. Tong is also on the board of YishengBio Co., Ltd. Mr. Tong previously occupied the position of Director-Global Research at Bank of America Merrill Lynch (New York), Research Analyst at Mehta Partners LLC, Executive Director-Investment Banking Research at UBS (China) Ltd., Research Analyst at Merrill Lynch Far East Ltd. and Analyst at UBS Securities (Asia) Ltd. Shaojing Tong received an MBA from New York University, a graduate degree from the University of Pittsburgh and an undergraduate degree from the University of Science & Technology of China.

Shao Jing Tong active positions

CompaniesPositionStart
REMEGEN CO., LTD. Director of Finance/CFO 28/09/2023
Director/Board Member -

Former positions of Shao Jing Tong

CompaniesPositionEnd
LAKESHORE BIOPHARMA CO., LTD Director/Board Member 29/02/2024
INNOCARE PHARMA LIMITED Director of Finance/CFO 31/12/2022
Analyst-Equity 31/05/2019
Corporate Officer/Principal 01/05/2019
Corporate Officer/Principal 01/05/2013
See the detail of Shao Jing Tong's experience

Training of Shao Jing Tong

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

95

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Finance

Consumer Services

Finance

Consumer Services

Consumer Services

Finance

Finance

Health Technology

Finance

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Shao Jing Tong
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!